Trials / Terminated
TerminatedNCT00232167
Study Of Indiplon/Placebo With Sertraline In Insomnia Co-Existing With Depression
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Of The Efficacy And Tolerability Of Indiplon Therapy Initiated With Sertraline Versus Sertraline Monotherapy In Subjects With Insomnia And Co-Existing Major Depressive Disorder
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 380 (planned)
- Sponsor
- Neurocrine Biosciences · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this study is to determine whether indiplon, when administered with sertraline, improves insomnia symptoms and depressive symptoms in subjects with both insomnia and depression.
Detailed description
This Pfizer run study stopped due to the co-development program for indiplon being terminated between Pfizer and Neurocrine. The study was terminated on 16 November 2006. There were no safety issues leading to the decision to terminate this study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Indiplon | |
| DRUG | Sertraline |
Timeline
- Start date
- 2005-11-01
- Completion
- 2006-04-01
- First posted
- 2005-10-04
- Last updated
- 2007-10-02
Source: ClinicalTrials.gov record NCT00232167. Inclusion in this directory is not an endorsement.